Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pmv Pharmaceuticals, Inc. (PMVP) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pmv Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1699382.
Total stock buying since 2020: $70,380,000.
Total stock sales since 2020: $59,642,456.
Total stock option exercises since 2020: $1,766,309.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 142,876 | $152,161 | 17,709 | $9,385 |
| 2024 | 0 | $0 | 10,109 | $15,203 | 91,750 | $48,627 |
| 2023 | 0 | $0 | 98,181 | $264,576 | 283,907 | $150,470 |
| 2022 | 0 | $0 | 500,753 | $10,682,625 | 57,000 | $57,770 |
| 2021 | 0 | $0 | 1,440,470 | $48,527,891 | 130,296 | $1,493,596 |
| 2020 | 3,910,000 | $70,380,000 | 0 | $0 | 4,070 | $6,461 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 142,876 | $152,161 | 0 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 17,709 | $9,385 |
| 2024-12 | 0 | $0 | 0 | $0 | 91,750 | $48,627 |
| 2024-09 | 0 | $0 | 10,109 | $15,203 | 0 | $0 |
| 2023-11 | 0 | $0 | 87,786 | $195,762 | 0 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 198,407 | $105,155 |
| 2023-09 | 0 | $0 | 10,395 | $68,814 | 0 | $0 |
| 2023-08 | 0 | $0 | 0 | $0 | 85,500 | $45,315 |
| 2022-05 | 0 | $0 | 26,253 | $418,210 | 0 | $0 |
| 2022-04 | 0 | $0 | 0 | $0 | 37,000 | $30,370 |
| 2022-03 | 0 | $0 | 474,500 | $10,264,415 | 20,000 | $27,400 |
| 2021-12 | 0 | $0 | 0 | $0 | 9,000 | $4,770 |
| 2021-10 | 0 | $0 | 12,441 | $374,512 | 0 | $0 |
| 2021-09 | 0 | $0 | 116,964 | $3,558,480 | 4,000 | $15,600 |
| 2021-08 | 0 | $0 | 499,034 | $16,823,592 | 21,896 | $59,327 |
| 2021-07 | 0 | $0 | 87,054 | $3,091,238 | 36,296 | $44,821 |
| 2021-06 | 0 | $0 | 205,216 | $6,899,834 | 12,604 | $1,305,369 |
| 2021-05 | 0 | $0 | 94,272 | $3,360,103 | 42,500 | $48,109 |
| 2021-04 | 0 | $0 | 230,730 | $7,846,633 | 4,000 | $15,600 |
| 2021-03 | 0 | $0 | 194,759 | $6,573,499 | 0 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 1,600 | $5,152 |
| 2020-11 | 0 | $0 | 0 | $0 | 2,470 | $1,309 |
| 2020-09 | 3,910,000 | $70,380,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | Carulli Michael (Chief Financial Officer) | Sale | 28,249 | 1.06 | 30,085 |
| 2025-07-01 | Jalota Deepika (Chief Development Officer) | Sale | 33,065 | 1.06 | 35,214 |
| 2025-07-01 | Ticktin Robert (General Counsel & COO) | Sale | 23,151 | 1.06 | 24,655 |
| 2025-07-01 | Mack David Henry (President and CEO) | Sale | 58,411 | 1.06 | 62,207 |
| 2025-01-03 | Mack David Henry (President and CEO) | Option Ex | 17,709 | .53 | 9,385 |
| 2024-12-03 | Mack David Henry (President and CEO) | Option Ex | 91,750 | .53 | 48,627 |
| 2024-09-11 | Carulli Michael (Chief Financial Officer) | Sale | 2,891 | 1.50 | 4,348 |
| 2024-09-11 | Jalota Deepika (Chief Development Officer) | Sale | 7,218 | 1.50 | 10,855 |
| 2023-11-22 | Orbimed Genesis Gp Llc | Sale | 87,786 | 2.23 | 195,762 |
| 2023-10-18 | Mack David Henry (President and CEO) | Option Ex | 198,407 | .53 | 105,155 |
| 2023-09-15 | Alland Leila (Chief Medical Officer) | Sale | 6,291 | 6.62 | 41,646 |
| 2023-09-15 | Jalota Deepika (Chief Development Officer) | Sale | 4,104 | 6.62 | 27,168 |
| 2023-08-07 | Mack David Henry (President and CEO) | Option Ex | 85,500 | .53 | 45,315 |
| 2022-05-26 | Orbimed Genesis Gp Llc | Sale | 26,253 | 15.93 | 418,210 |
| 2022-04-27 | Mack David Henry (President and CEO) | Option Ex | 33,000 | .53 | 17,490 |
| 2022-04-20 | Kung Winston (COO, CFO) | Option Ex | 4,000 | 3.22 | 12,880 |
| 2022-03-31 | Orbimed Capital Llc | Sale | 34,500 | 21.17 | 730,365 |
| 2022-03-30 | Orbimed Capital Llc | Sale | 75,000 | 22.39 | 1,679,250 |
| 2022-03-29 | Orbimed Capital Llc | Sale | 365,000 | 21.52 | 7,854,800 |
| 2022-03-08 | Mack David Henry (President and CEO) | Option Ex | 20,000 | 1.37 | 27,400 |
| 2021-12-15 | Mack David Henry (President and CEO) | Option Ex | 9,000 | .53 | 4,770 |
| 2021-10-06 | Schroeder Thilo (Director) | Sale | 800 | 30.15 | 24,120 |
| 2021-10-04 | Schroeder Thilo (Director) | Sale | 100 | 30.08 | 3,008 |
| 2021-10-01 | Schroeder Thilo (Director) | Sale | 11,541 | 30.10 | 347,384 |
| 2021-09-30 | Schroeder Thilo (Director) | Sale | 2,978 | 30.03 | 89,429 |
| 2021-09-29 | Schroeder Thilo (Director) | Sale | 5,708 | 30.04 | 171,468 |
| 2021-09-27 | Schroeder Thilo (Director) | Sale | 1,753 | 30.11 | 52,782 |
| 2021-09-22 | Schroeder Thilo (Director) | Sale | 100 | 30.00 | 3,000 |
| 2021-09-22 | Levine Arnold J (Director) | Sale | 3,500 | 30.00 | 105,000 |
| 2021-09-17 | Schroeder Thilo (Director) | Sale | 711 | 30.03 | 21,351 |
| 2021-09-13 | Schroeder Thilo (Director) | Sale | 13,272 | 30.20 | 400,814 |
| 2021-09-10 | Schroeder Thilo (Director) | Sale | 43,227 | 30.73 | 1,328,581 |
| 2021-09-09 | Alland Leila (Chief Medical Officer) | Sale | 100 | 30.25 | 3,025 |
| 2021-09-09 | Alland Leila (Chief Medical Officer) | Option Ex | 100 | 3.90 | 390 |
| 2021-09-09 | Schroeder Thilo (Director) | Sale | 14,329 | 30.31 | 434,311 |
| 2021-09-07 | Alland Leila (Chief Medical Officer) | Sale | 3,900 | 30.25 | 117,975 |
| 2021-09-07 | Alland Leila (Chief Medical Officer) | Option Ex | 3,900 | 3.90 | 15,210 |
| 2021-09-02 | Schroeder Thilo (Director) | Sale | 5,400 | 30.15 | 162,810 |
| 2021-09-01 | Schroeder Thilo (Director) | Sale | 21,986 | 30.38 | 667,934 |
| 2021-08-31 | Schroeder Thilo (Director) | Sale | 19,520 | 30.12 | 587,942 |
| 2021-08-30 | Schroeder Thilo (Director) | Sale | 13,233 | 30.05 | 397,651 |
| 2021-08-27 | Schroeder Thilo (Director) | Sale | 24,442 | 30.78 | 752,324 |
| 2021-08-26 | Schroeder Thilo (Director) | Sale | 21,154 | 30.76 | 650,697 |
| 2021-08-25 | Schroeder Thilo (Director) | Sale | 13,526 | 31.01 | 419,441 |
| 2021-08-24 | Schroeder Thilo (Director) | Sale | 14,490 | 31.08 | 450,349 |
| 2021-08-23 | Schroeder Thilo (Director) | Sale | 23,838 | 30.86 | 735,640 |
| 2021-08-23 | Levine Arnold J (Director) | Sale | 3,500 | 29.50 | 103,250 |
| 2021-08-19 | Schroeder Thilo (Director) | Sale | 3,800 | 30.97 | 117,686 |
| 2021-08-19 | Kung Winston (COO, CFO) | Option Ex | 5,000 | 3.22 | 16,100 |
| 2021-08-19 | Mack David Henry (President and CEO) | Option Ex | 5,500 | .53 | 2,915 |
| 2021-08-18 | Schroeder Thilo (Director) | Sale | 26,864 | 33.58 | 902,012 |
| 2021-08-17 | Jalota Deepika (SVP, Regulatory Affairs and QA) | Sale | 2,896 | 33.78 | 97,815 |
| 2021-08-17 | Jalota Deepika (SVP, Regulatory Affairs and QA) | Option Ex | 2,896 | 3.53 | 10,222 |
| 2021-08-17 | Schroeder Thilo (Director) | Sale | 31,022 | 33.57 | 1,041,408 |
| 2021-08-16 | Schroeder Thilo (Director) | Sale | 22,183 | 34.17 | 757,993 |
| 2021-08-13 | Schroeder Thilo (Director) | Sale | 27,286 | 34.44 | 939,729 |
| 2021-08-12 | Schroeder Thilo (Director) | Sale | 13,536 | 34.59 | 468,210 |
| 2021-08-11 | Schroeder Thilo (Director) | Sale | 34,439 | 34.04 | 1,172,303 |
| 2021-08-10 | Schroeder Thilo (Director) | Sale | 20,505 | 35.15 | 720,750 |
| 2021-08-09 | Alland Leila (Chief Medical Officer) | Sale | 4,471 | 34.80 | 155,604 |
| 2021-08-09 | Alland Leila (Chief Medical Officer) | Option Ex | 4,000 | 3.90 | 15,600 |
| 2021-08-09 | Schroeder Thilo (Director) | Sale | 22,182 | 35.95 | 797,509 |
| 2021-08-06 | Schroeder Thilo (Director) | Sale | 19,900 | 36.77 | 731,822 |
| 2021-08-05 | Schroeder Thilo (Director) | Sale | 35,611 | 36.54 | 1,301,225 |
| 2021-08-04 | Schroeder Thilo (Director) | Sale | 52,860 | 35.58 | 1,880,864 |
| 2021-08-03 | Schroeder Thilo (Director) | Sale | 30,245 | 34.27 | 1,036,496 |
| 2021-08-03 | Kung Winston (COO, CFO) | Sale | 4,500 | 33.82 | 152,176 |
| 2021-08-03 | Kung Winston (COO, CFO) | Option Ex | 4,500 | 3.22 | 14,490 |
| 2021-08-02 | Schroeder Thilo (Director) | Sale | 13,031 | 34.74 | 452,696 |
| 2021-07-29 | Schroeder Thilo (Director) | Sale | 2,300 | 35.73 | 82,179 |
| 2021-07-28 | Schroeder Thilo (Director) | Sale | 8,724 | 35.76 | 311,970 |
| 2021-07-27 | Schroeder Thilo (Director) | Sale | 535 | 35.61 | 19,051 |
| 2021-07-26 | Schroeder Thilo (Director) | Sale | 4,839 | 35.73 | 172,897 |
| 2021-07-23 | Schroeder Thilo (Director) | Sale | 11,988 | 36.00 | 431,568 |
| 2021-07-22 | Schroeder Thilo (Director) | Sale | 200 | 35.61 | 7,122 |
| 2021-07-21 | Schroeder Thilo (Director) | Sale | 18,672 | 35.82 | 668,831 |
| 2021-07-21 | Mack David Henry (President and CEO) | Sale | 26,767 | 35.76 | 957,080 |
| 2021-07-21 | Mack David Henry (President and CEO) | Option Ex | 26,767 | .53 | 14,186 |
| 2021-07-20 | Mack David Henry (President and CEO) | Sale | 1,029 | 35.53 | 36,560 |
| 2021-07-20 | Mack David Henry (President and CEO) | Option Ex | 1,029 | .53 | 545 |
| 2021-07-20 | Levine Arnold J (Director) | Sale | 3,500 | 35.12 | 122,930 |
| 2021-07-08 | Kung Winston (COO, CFO) | Sale | 4,500 | 33.75 | 151,875 |
| 2021-07-08 | Kung Winston (COO, CFO) | Option Ex | 4,500 | 3.22 | 14,490 |
| 2021-07-07 | Alland Leila (Chief Medical Officer) | Sale | 4,000 | 32.29 | 129,175 |
| 2021-07-07 | Alland Leila (Chief Medical Officer) | Option Ex | 4,000 | 3.90 | 15,600 |
| 2021-06-28 | Mack David Henry (President and CEO) | Sale | 204 | 35.53 | 7,248 |
| 2021-06-28 | Mack David Henry (President and CEO) | Option Ex | 204 | .53 | 108 |
| 2021-06-21 | Levine Arnold J (Director) | Sale | 3,500 | 33.65 | 117,782 |
| 2021-06-14 | Simons James H (10% Owner) | Sale | 44,419 | 34.11 | 1,515,132 |
| 2021-06-11 | Simons James H (10% Owner) | Sale | 21,977 | 33.80 | 742,822 |
| 2021-06-10 | Simons James H (10% Owner) | Sale | 20,633 | 32.68 | 674,286 |
| 2021-06-09 | Simons James H (10% Owner) | Sale | 39,638 | 33.64 | 1,333,422 |
| 2021-06-08 | Simons James H (10% Owner) | Sale | 31,724 | 33.38 | 1,058,947 |
| 2021-06-07 | Alland Leila (Chief Medical Officer) | Sale | 4,000 | 33.70 | 134,780 |
| 2021-06-07 | Alland Leila (Chief Medical Officer) | Option Ex | 4,000 | 3.90 | 15,600 |
| 2021-06-07 | Simons James H (10% Owner) | Sale | 30,721 | 33.62 | 1,032,840 |
| 2021-06-04 | Kung Winston (COO, CFO) | Sale | 4,500 | 33.75 | 151,875 |
| 2021-06-04 | Kung Winston (COO, CFO) | Option Ex | 4,500 | 3.22 | 14,490 |
| 2021-06-01 | Heyman Richard A. (Director) | Sale | 3,900 | 33.51 | 130,700 |
| 2021-06-01 | Heyman Richard A. (Director) | Option Ex | 3,900 | 326.97 | 1,275,171 |
| 2021-05-28 | Schroeder Thilo (Director) | Sale | 5,100 | 35.80 | 182,580 |
| 2021-05-26 | Schroeder Thilo (Director) | Sale | 7,487 | 35.66 | 266,986 |
| 2021-05-25 | Schroeder Thilo (Director) | Sale | 8,518 | 35.91 | 305,881 |
| 2021-05-24 | Schroeder Thilo (Director) | Sale | 22,095 | 36.03 | 796,082 |
| 2021-05-21 | Schroeder Thilo (Director) | Sale | 19,774 | 35.84 | 708,700 |
| 2021-05-21 | Mack David Henry (President and CEO) | Sale | 6,207 | 35.71 | 221,639 |
| 2021-05-21 | Mack David Henry (President and CEO) | Option Ex | 6,207 | .53 | 3,289 |
| 2021-05-20 | Schroeder Thilo (Director) | Sale | 2,911 | 35.65 | 103,777 |
| 2021-05-20 | Mack David Henry (President and CEO) | Sale | 7,793 | 35.60 | 277,454 |
| 2021-05-20 | Mack David Henry (President and CEO) | Option Ex | 17,793 | .53 | 9,430 |
| 2021-05-20 | Levine Arnold J (Director) | Sale | 3,500 | 34.12 | 119,423 |
| 2021-05-10 | Schroeder Thilo (Director) | Sale | 1,787 | 35.67 | 63,742 |
| 2021-05-07 | Alland Leila (Chief Medical Officer) | Sale | 4,000 | 35.15 | 140,580 |
| 2021-05-07 | Alland Leila (Chief Medical Officer) | Option Ex | 4,000 | 3.90 | 15,600 |
| 2021-05-05 | Schroeder Thilo (Director) | Sale | 600 | 35.64 | 21,384 |
| 2021-05-03 | Kung Winston (COO, CFO) | Sale | 4,500 | 33.75 | 151,875 |
| 2021-05-03 | Kung Winston (COO, CFO) | Option Ex | 4,500 | 3.22 | 14,490 |
| 2021-04-12 | Schroeder Thilo (Director) | Sale | 3,903 | 32.09 | 125,258 |
| 2021-04-09 | Schroeder Thilo (Director) | Sale | 25,763 | 34.32 | 884,186 |
| 2021-04-08 | Schroeder Thilo (Director) | Sale | 33,322 | 34.02 | 1,133,781 |
| 2021-04-07 | Alland Leila (Chief Medical Officer) | Sale | 4,000 | 34.14 | 136,556 |
| 2021-04-07 | Alland Leila (Chief Medical Officer) | Option Ex | 4,000 | 3.90 | 15,600 |
| 2021-04-07 | Schroeder Thilo (Director) | Sale | 24,457 | 34.19 | 836,184 |
| 2021-04-06 | Schroeder Thilo (Director) | Sale | 78,657 | 34.26 | 2,694,788 |
| 2021-04-05 | Schroeder Thilo (Director) | Sale | 48,193 | 33.74 | 1,626,272 |
| 2021-04-01 | Schroeder Thilo (Director) | Sale | 12,435 | 32.94 | 409,608 |
| 2021-03-31 | Schroeder Thilo (Director) | Sale | 33,626 | 32.15 | 1,081,075 |
| 2021-03-30 | Schroeder Thilo (Director) | Sale | 22,483 | 31.00 | 697,085 |
| 2021-03-29 | Schroeder Thilo (Director) | Sale | 2,174 | 32.38 | 70,394 |
| 2021-03-26 | Schroeder Thilo (Director) | Sale | 35,268 | 33.44 | 1,179,361 |
| 2021-03-25 | Schroeder Thilo (Director) | Sale | 66,327 | 33.98 | 2,253,592 |
| 2021-03-24 | Schroeder Thilo (Director) | Sale | 34,881 | 37.04 | 1,291,992 |
| 2020-12-08 | Kung Winston (COO, CFO) | Option Ex | 1,600 | 3.22 | 5,152 |
| 2020-11-18 | Mack David Henry (President and CEO) | Option Ex | 2,470 | .53 | 1,309 |
| 2020-09-29 | Shah Rajeev M. | Buy | 950,000 | 18.00 | 17,100,000 |
| 2020-09-25 | Davis Aaron I. (Other) | Buy | 950,000 | 18.00 | 17,100,000 |
| 2020-09-25 | Thompson Peter A. (Director) | Buy | 950,000 | 18.00 | 17,100,000 |
| 2020-09-25 | Kliman Gilbert H (10% Owner) | Buy | 55,000 | 18.00 | 990,000 |
| 2020-09-25 | Oronsky Arnold L (Director) | Buy | 55,000 | 18.00 | 990,000 |
| 2020-09-25 | Orbimed Capital Llc (Director) | Buy | 950,000 | 18.00 | 17,100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of PMVP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pmv Pharmaceuticals, Inc. (symbol PMVP, CIK number 1699382) see the Securities and Exchange Commission (SEC) website.